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Summary
Background: Candiduria is a hospital-associated infection and a daily problem in the intensive
care unit. The treatment of asymptomatic candiduria is not well established and the use of
amphotericin B bladder irrigation (ABBI) is controversial. The aim of this systematic review was to
determine the best place for this therapy in practice.
Methods: The databases searched in this study included MEDLINE, EMBASE, Web of Science, and
LILACS (January 1960—June 2007). We included manuscripts with data on the treatment of
candiduria using ABBI. The studies were classified as comparative, dose-finding, or non-com-
parative.
Results: From 213 studies, nine articles (377 patients) met our inclusion criteria. ABBI showed a
higher clearance of the candiduria 24 hours after the end of therapy than fluconazole (odds ratio
(OR) 0.57, 95% confidence interval (CI) 0.32—1.00). Fungal culture 5 days after the end of both
therapies showed a similar response (OR 1.51, 95% CI 0.81—2.80). The evaluation of ABBI using an
intermittent or continuous system of delivery showed an early candiduria clearance (24 hours
after therapy) of 80% and 82%, respectively (OR 0.87, 95% CI 0.52—1.36). Candiduria clearance at
>5 days after the therapy showed a superior response using continuous bladder irrigation with
amphotericin B (OR 0.52, 95% CI 0.29—0.94). The use of continuous ABBI for more than 5 days
showed a better result (88% vs. 78%) than ABBI for less than 5 days, but without significance (OR
0.55, 95% CI 0.34—1.04).
* Corresponding author. Tel.: +55 11 30696530; fax: +55 11 30697508.
E-mail address: ffbt@pop.com.br (F.F. Tuon).
1201-9712/$36.00 # 2008 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
doi:10.1016/j.ijid.2008.10.012
Conclusion: Although the strength of the results in the underlying literature is not sufficient to
allow the drawing of definitive conclusions, ABBI appears to be as effective as fluconazole, but it
does not offer systemic antifungal therapy and should only be used for asymptomatic candiduria.
# 2008 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
702 F.F. Tuon et al.Introduction
Candiduria is a hospital-associated infection with increasing
frequency, although most of these cases have been consid-
ered as contamination. Furthermore, patients with diabetes
mellitus or a urinary catheter outside the hospital also have a
high prevalence of candiduria. In a previous study, 5% of the
urine cultures from a large metropolitan teaching-hospital
were positive for fungi.1 Also, it was reported that almost 25%
of hospitalized nursing-home patients with indwelling urinary
catheters had urine cultures positive for yeast cells.2 After
contamination, the second cause of candiduria is coloniza-
tion. These two fungal problems are recognized after repeti-
tion of the urine culture plus association with common risk
factors, such as antibiotic use and presence of an indwelling
urinary catheter.
Clinicians have experienced difficulties managing candi-
duria in the intensive care unit. Several guidelines have been
published, but controversies about its management con-
tinue. Candiduria can be related to Candida pyelonephritis,
candidemia, Candida cystitis, or may be asymptomatic. The
differential diagnosis of these conditions is difficult. Candida
cystitis is very rare because the bladder wall is extremely
resistant. Candida pyelonephritis is also rare and always
associated with systemic signs and urinary tract obstruction.
Currently, there is no method of differentiating upper tract
from lower tract candidiasis, and pathognomonic signs of
upper infections such as Candida casts and fungal balls on
ultrasound are extremely rare. The main reason why clin-
icians treat patients with asymptomatic candiduria is the risk
of associated candidemia. Candiduria can be associated with
fungemia inmore than 10% of cases, and PCRof blood samples
from patients with candiduria increases the diagnosis rate of
candidemia.3 However no difference in genetic background
between blood and urine strains of Candida species has been
found.4
The treatment of asymptomatic candiduria (without
fever) is not well established because the natural history
of this entity is unknown. It has been shown that continuous
amphotericin B bladder irrigation eradicates the lower tract
Candida infection or colonization, and is a potentially useful
test for locating the site of infection (upper or lower).2
The treatment of candiduria with amphotericin B bladder
irrigation (ABBI) is controversial. Recent studies have shown
the efficacy of azoles in the treatment of asymptomatic
candiduria, and ABBI treatment has, for the most part, been
abandoned. Some clinical trials have compared the two
methods of treatment, however, doubts remain.
Amphotericin was discovered more than 50 year ago and
its use in bladder irrigation was described in 1960.5 Since
then, several manuscripts on its use have been published, but
information on the dose, duration, and method of ABBI is
lacking. In this systematic review we performed an extensive
search of articles on this subject; most of them are reviews
and expert opinions. We listed all the in vivo studies to showthe evidence in the literature on the use of amphotericin by
this route, and sought to determine the best place for this
therapy in practice.
Materials and methods
Search strategy
A systematic search of the medical literature was performed
as previously described.6—8 The databases searched included
MEDLINE, EMBASE, Web of Science, and LILACS (January
1960—June 2007), as well as the Cochrane Library database
up to 2007. The search terms used were ‘amphotericin’,
‘irrigation’, and ‘catheter’. Other search terms used were:
‘candiduria’, ‘funguria’, ‘candidiasis’, and ‘bladder’. Biblio-
graphies from the studies were also reviewed.
Study selection
The articles were selected with no language restriction. We
included manuscripts with data on the treatment of candi-
duria using ABBI. The diagnosis of candiduria was based on
quantitative or qualitative culture, with Candida spp in at
least two samples. The studies were classified as comparative
(ABBI vs. another drug), dose-finding (comparisons of differ-
ent dosing regimens of ABBI), or non-comparative (single-
armed studies). For the comparative and dose-finding studies
we assessed the adequacy of methods for further calculation
and, if possible, included these in a meta-analysis. Single-
armed studies were allocated sequentially and response to
treatment was evaluated (see data extraction).
Data extraction
Cases included patients with diagnostic criteria for asympto-
matic candiduria defined microbiologically, as previously
described.9 All studies needed to provide (1) data necessary
for the computation of the clearance and treatment failure
of the candiduria; (2) information to establish internal and
external validity: randomized, blinded, prospective, con-
trolled (placebo vs. other drug), number and age of patients,
patient origin and follow-up, culture methodology; (3) indi-
cation of fungal therapy; (4) the dose, duration, and method
(intermittent vs. continuous) of ABBI; (5) the dose and
duration of the other antifungal therapy (controlled trial).
Statistical analysis
The validation of this systematic review was based on guide-
lines to guarantee quality, as well as good article selection
and data extraction.10—12 The parameters evaluated were:
fluconazole vs. ABBI, continuous vs. intermittent ABBI, and
continuous ABBI for less than 5 days vs. ABBI for more than 5
days. Candiduria clearance was compared by percentage of
Figure 1 Selection of the studies included in the meta-analysis
of the use of amphotericin B bladder irrigation in the treatment
of asymptomatic candiduria.
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Amphotericin B and fungal urinary tract infection 703response using urine culture at 24—72 hours (early) and after
5 days (late); Chi-square odds ratios (OR) and 95% confidence
intervals (CI) were calculated using SPSS 11.5 and signifi-
cance was set at a p value of <0.05.
Results
Description of studies included
The search strategy yielded a total of 213 studies, of which
182 were excluded after initial screening. From the 31
remaining articles, nine (377 patients) met the inclusion
criteria. The number of controlled and randomized studies
was sufficient to perform a meta-analysis (Figure 1).
Study validity and data quality
Of the nine studies selected, 2,18—23all were prospective with
hospitalized adult patients. Five studies were randomized
and controlled. Data on the method of diagnosis and species
found are described in Table 1. Three studies compared ABBI
with intravenous fluconazole. All studies allowed a compar-
ison of indirectly continuous vs. intermittent ABBI. Studies
that evaluated continuous ABBI allowed the comparison of
more than 5 days of therapy against less than 5 days.
Results of the variables
In comparison with intravenous fluconazole, ABBI showed a
higher clearance of the candiduria 24 hours after the end of
therapy (OR 0.57, 95% CI 0.32—1.00). Fungal culture 5 days
after the end of both therapies showed a similar response (OR
1.51, 95% CI 0.81—2.80) (Figure 2; Table 2).
Figure 2 Comparison between amphotericin B bladder irriga-
tion (intermittent or continuous) and fluconazole in the treat-
ment of asymptomatic candiduria. The relative risk is related to
candiduria persistence. The upper graph shows the evaluation of
urine culture 24 hours after therapy and the lower graph shows
the evaluation of urine culture 1 week after therapy.
704 F.F. Tuon et al.The evaluation of ABBI using an intermittent or continuous
system of delivery showed an early candiduria clearance
(24 hours after therapy) of 80% for intermittent and 82%
for continuous (OR 0.87, 95% CI 0.52—1.36). The candiduria
clearance at 7 days after the therapy showed a superior
response using continuous bladder irrigation with amphoter-
icin B (79%) vs. intermittent irrigation (60%) (OR 0.52, 95% CI
0.29—0.94) (Table 3).Table 2 Studies comparing fluconazole and amphotericin B blad
Author, year, country N Indication Drug
Jacobs, 1996, USA 39 Persistent candiduria AmphBcont
29 Fluconazole
Leu, 199519, China 30 Persistent candiduria AmphBint
30 AmphBint
29 Fluconazole
Fan-Havard,
199523, USA
17 Persistent candiduria AmphBcont
18 AmphBcont
18 Fluconazole
AmphBcont, continuous bladder irrigation with amphotericin B; AmphThe use of continuous bladder irrigation with amphoter-
icin B for more than 5 days showed a better result than ABBI
for less than 5 days (88% versus 78%), but without significance
(OR 0.55, 95% CI 0.34—1.04) (Table 4).
Discussion
This meta-analysis compared the different methods used to
treat asymptomatic candiduria, showing a better clearance
of the Candida in the first days using amphotericin B irrigation
than fluconazole, but with no difference between these
approaches after one week. Considering this fact, clinicians
may use either therapy. If ABBI is the preferred method, a
continuous delivery over 5 days is the ideal. Sobel et al.
compared fungal eradication using fluconazole or placebo
daily for 14 days, in 316 patients with asymptomatic candi-
duria.13 Fluconazole cleared candiduria by day 14 in 50%; this
was only 29% in the placebo group. Unfortunately, cultures at
2 weeks revealed similar candiduria rates among treated and
untreated patients using a bladder catheter. This study
showed that treatment may result in a short-term clearance
of the colonization, but that catheter removal is the main
treatment required to avoid new colonization and further
infection.14
The heterogeneity of data from our study does not allow
us to confirm the results. It was not possible to draw any
definitive conclusions from the comparison of fluconazole
and intermittent or continuous ABBI and the duration of ABBI.
This meta-analysis has several biases. The selection of the
studies was done well, but data extraction was difficult.
Papers used different inclusion criteria for patients, the
method of culture was often poorly described, and we could
not separate studies using quantitative from qualitative
methods. Although all studies were prospective, patient
underlying diseases were not described. We believe that this
was the greatest problem in this meta-analysis. The duration
of follow-up of the patients was short; a 30-day follow-up
should be performed, including the rate of mortality, to
determine the real benefits of therapy against candiduria.
ABBI requires the use of a new three-way catheter and
drug disposal by an uncommon route. Fong et al.18 deter-
mined the minimal concentration of amphotericin B neces-
sary to kill Candida in urine samples from hospitalized
patients. Nevertheless, this study determined in vitro mea-
sures and several articles from this systematic review showed
positive urine for Candida 24 hours after therapy.der irrigation in the treatment of asymptomatic candiduria.
Dose Duration
(mean)
Clearance of
candiduria
(24 hours)
% Clearance
of candiduria
(>5 days)
%
50 mg/l 5 days 33 85% 13/17 76%
100 mg 4 days 20 69% 15/19 79%
100 mg/l 3 26 87% 13/19 68%
200 mg/l 3 25 83% 15/22 68%
100 mg 4 days 17 59% 17/22 77%
50 mg/l 1 day 14 82% 9/12 75%
50 mg/l 7 days 17 94% 11/14 79%
100 mg 7 days 15 83% 10/13 77%
Bint, intermittent bladder irrigation with amphotericin B.
Table 3 Studies comparing continuous and intermittent amphotericin B bladder irrigation in the treatment of asymptomatic
candiduria.
Author, year, country N Indication Dose Duration
(mean)
Clearance
of candiduria
(24 hours)
% Clearance of
candiduria
(>5 days)
%
Continuous bladder irrigation with amphotericin B
Nesbit, 1999, USA 13 Candiduria 10 mg/l 3 days 8 62%
13 50 mg/l 3 days 13 100%
Wise, 198221, USA 40 Persistent candiduria 50 mg/l 6 days 37 93% 12/14 86%
Wise, 197322, USA 10 Persistent candiduria 50 mg/l 5 days 7 70%
Jacobs, 1996, USA 39 Funguria 50 mg/l 5 days 33 85% 13/17 76%
Trinh, 199520, USA 10 Candiduria 50 mg/l 2 days 8 80%
Fan-Havard, 199523, USA 17 Persistent candiduria 50 mg/l 1 day 14 82% 9/12 75%
18 7 days 17 94% 11/14 79%
Hsu, 19902, China 65 Candiduria 50 mg/l 2 days 47 72%
Total 225 184 82% 45/57 79%
Intermittent bladder irrigation with amphotericin B
Trinh, 199520, USA 10 Candiduria 10 mg/100 ml 3/24 h 3 30%
Leu, 199519, China 28 Persistent candiduria 1 mg/200 ml 3/24 h 23 82% 9/21 43%
30 20 mg/200 ml 3/24 h 26 87% 13/19 68%
30 40 mg/200 ml 3/24 h 25 83% 15/22 68%
Fong, 199518, Canada 54 Persistent candiduria 30 mg/100 ml 1/24 h 44 81%
Total 152 121 80% 37/62 60%
Amphotericin B and fungal urinary tract infection 705A major problem of ABBI is the scarcity of publications
using the same method to compare with other therapies.
We showed that continuous irrigation is better than
intermittent. Therefore, we investigated the duration of
continuous irrigation. The use of ABBI for a median of 2
days was less effective than its use for a median of 5.5
days.
Several opinions have been published recommending
abandoning the use of ABBI. Drew et al. considered that ABBI
is rarely needed in present day clinical practice, and that
other therapeutic modalities should be used.15 Nevertheless,
amphotericin is easy to administer, does not have drug
interactions, and is useful in anuric patients with purulent
cystitis caused by Candida and other yeasts.Table 4 Studies comparing different time-periods of continu
asymptomatic candiduria.
Author, year, country N Indication
Continuous bladder irrigation with amphotericin B (<5 days)
Nesbit, 1999, USA 13 Candiduria
Trinh, 199520, USA 10 Candiduria
Hsu, 19902, China 65 Candiduria
Fan-Havard, 199523, USA 17 Persistent candiduria
Total 105
Continuous bladder irrigation with amphotericin B (5 days)
Fan-Havard, 199523, USA 18 Persistent candiduria
Wise, 198221, USA 40 Persistent candiduria
Wise, 197322, USA 10 Persistent candiduria
Jacobs, 1996, USA 39 Funguria
Total 107Untreated candiduria may lead to further complications,
such as fungus ball formation, systemic dissemination, or
renal candidiasis, due to the spread of infection by the
ascending route, mainly in oliguric patients. Nevertheless,
these events are very rare. Whether or not any candiduria
requires treatment is controversial. Candiduria will sponta-
neously remit without therapy, although this may take sev-
eral months.16 One study, however, indicated that mortality
increased significantly in patients with candiduria who did
not receive antifungal treatment.17
Although the strength of the underlying literature is not
sufficient to allow the drawing of definitive conclusions, we
believe that ABBI can be used in patients with asymptomatic
candiduria showing risk of dissemination (pyuria, oliguria,ous amphotericin B bladder irrigation in the treatment of
Dose Duration (mean) Clearance of
candiduria
%
50 mg/l 3 days 13 100%
50 mg/l 2 days 8 80%
50 mg/l 2 days 47 72%
50 mg/l 1 day 14 82%
82 78%
50 mg/l 7 days 17 94%
50 mg/l 6 days 37 93%
50 mg/l 5 days 7 70%
50 mg/l 5 days 33 85%
94 88%
706 F.F. Tuon et al.urinary tract obstruction, patients using cystostomy). ABBI
appears to be as effective as fluconazole, and the best
method involves continuous irrigation for more than 5 days.
Local irrigation does not offer systemic antifungal therapy
and should only be used for asymptomatic candiduria.
A practicing urologist, Gilbert Wise, said: ‘‘until such time
as an effective treatment is available, amphotericin B irriga-
tion should remain in the armamentarium of the clinician’’.
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